Trump’s cheap fat drugs

border_humper

border_humper

Staff Member
Moderator
Chief Disinfo Officer

Trump Strikes Deal With Lilly And Novo To Offer "Drastic Discounts" On Weight-Loss Drugs | ZeroHedge

ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero
www.zerohedge.com www.zerohedge.com

Eli Lilly & Co. and Novo Nordisk A/S struck a deal with the Trump administration to offer their blockbuster obesity drugs at lower prices in exchange for tariff relief and expanded Medicare access. The announcement was made in the Oval Office early this afternoon, where President Trump told reporters, "I call it the fat drug ... we're offering it at drastic discounts."
Click to expand...
Where’s Canada’s cheap fat shots? Will be hilarious if Americans all get skinny while Canadians stay fat.
 
Upvote 10
It's already cheaper. In the US you would have to pay about $950 for a 30 day supply of Ozempic. In Canada it would cost you $170 for the same supply. In both cases without any insurance covering the cost. So if Trump didn't negotiate a 80% reduction, it will be still cheaper here.
 
Still good publicity whatever he got. This fucker's going to be overjoyed!

2388e773-b8db-44e2-af85-b978547c5e5a-AP23162620867239.jpg
 
That "fat drug" has been out awhile now with wide use. Maybe it's alright? Or does it make your asshole fall out?

It would be pretty cool if Trump whipped the whole country into shape except it's the 2025 way of using drugs instead of exercising.
 
if you need a drug to make you skinny then you get what you get. Didnt some guy collapse during the sales pitch in the oval office for this stuff that is responsible for this stuff??

Everybody works out and nobody quits that how you get lean and strong / feel good

Socrates stated "no man has the right to be an amateur in the matter of physical training. it is a shame for a man to grow old without seeing the beauty and strength of which his body is capable."

Socrates wasnt / isnt wrong
 
Some interesting facts about these "Fat Drugs". For anyone interested.

Connection Between Gila Monsters, Anglerfish, and Ozempic​

The development of Ozempic (active ingredient: semaglutide) is deeply rooted in natural compounds discovered in Gila monster venom and early research on anglerfish, representing a remarkable convergence of evolutionary biology and pharmaceutical science.

1. Gila Monster Venom and Exendin-4​

The Gila monster (Heloderma suspectum), a venomous lizard native to the southwestern U.S., produces a hormone in its saliva called exendin-4. This compound is structurally 50% homologous to the human hormone glucagon-like peptide-1 (GLP-1), which regulates blood sugar and appetite by stimulating insulin release.
Unlike human GLP-1, which degrades within minutes, exendin-4 remains active for hours, making it an ideal candidate for drug development. In the early 1990s, Dr. John Eng, a researcher at the Bronx Veterans Affairs Medical Center, isolated this peptide and patented it. His work led to the creation of exenatide (brand name Byetta), the first GLP-1 receptor agonist approved by the FDA in 2005 for type 2 diabetes.

Gila monsterspecies of venomous lizard from the southwestern United States and northwestern Mexico
Wikipedia
Gila_monster2.JPG



2. Evolution to Semaglutide (Ozempic)​

Building on exendin-4, scientists engineered semaglutide, a synthetic analog designed for even greater stability and efficacy. Semaglutide mimics GLP-1 but resists enzymatic breakdown, allowing for once-weekly injections. It not only improves glycemic control in diabetics but also significantly reduces appetite and slows gastric emptying, leading to substantial weight loss.
Though Novo Nordisk (maker of Ozempic) states their development was based on human GLP-1 biology, they acknowledge that exendin-4's discovery was a pivotal contribution to the field.
Semaglutide=Modified GLP-1 analog with extended half-life

3. Role of Anglerfish in Early GLP-1 Discovery​

While Gila monsters provided the durable hormone template, the anglerfish played a foundational role. In the 1980s, researchers studying deep-sea anglerfish used recombinant DNA technology to identify proglucagon, the precursor to GLP-1. This discovery enabled the identification of GLP-1 in humans and its insulinotropic effects—stimulating insulin secretion in response to elevated blood glucose
Click to expand...
It explains why most of the side effects are consistent with poisoning.
 
You must log in or register to reply here.
Back
Top